Skip to main content

Advertisement

SpringerLink
Log in

Phase I/II study of selective cyclooxygenase-2 inhibitor celecoxib as a radiation sensitizer in patients with unresectable brain metastases

  • Clinical Study
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Summary

PurposeThe primary goal of this phase I/II study was to evaluate the feasibility, safety and efficacy of celecoxib administered concomitant to radiotherapy to treat unresectable BM. Patients and methods: Patients with measurable BM by CT or MRI, unresectability criteria by a neurosurgeon and RPA-RTOG class II were eligible. Celecoxib was administered at 400 mg/day during the entire course of radiotherapy. All patients were irradiated with 60Co beams to whole-brain dose of 32 Gy (20 fractions of 1.6 Gy each two times a day with a 6 h interval between treatments) followed by a 22.4 Gy boost (same fractionation schedule) over evident lesions. Results: Twenty-seven patients were treated. The concurrent regimen was well tolerated with 15 cases of mild dyspepsia. Alopecia (NCI grades 1–2) was the most important side effect. Three patients presented rash/desquamation of moderate intensity. Radiological responses occurred in 18 of 25 valuable patients (72), with five complete responses (CR). Symptomatic responses were reported in 25 of 27 patients (92.6), with 20 CR. The overall response rate (considering complete plus partial responses) was 66.7. Percentile 50 for time-to-progression, time-to-neurological-progression and functional-independence-time were 3, 6.25 and 6.7 months, respectively. Median survival time was 8.7 months. Conclusion: Our initial results suggest that radiotherapy plus celecoxib is safe and a possible active treatment for patients with BM. Further investigation in a randomized trial is warranted to validate its clinical utility.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • AE Walker M Robins FD Weinfeld (1985) ArticleTitleEpidemiology of brain tumors: the national survey of intracranial neoplasms Neurology 35 219–224 Occurrence Handle1:STN:280:BiqC3M7lsVE%3D Occurrence Handle3969210

    CAS  PubMed  Google Scholar 

  • L Gaspar C Scott M Rotman S Asbell T Phillips T Wasserman WG McKenna R Byhardt (1997) ArticleTitleRecursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials Int J Radiat Oncol Biol Phys 37 745–751

    Google Scholar 

  • LE Gaspar C Scott KJ Murray W Curran (2000) ArticleTitleValidation of the RTOG recursive partitioning analysis classification for brain metastases Int J Radiat Oncol Biol Phys 47 1001–1006

    Google Scholar 

  • O Agboola B Benoit C Cross V Da Silva B Esche H Lesiuk C Gonsalves (1998) ArticleTitlePrognostic factors derived from recursive partition analysis (RPA) of Radiation Therapy Oncology Group (RTOG) brain metastases trials applied to surgically resected and irradiated brain metastatic cases Int J Radiation Oncol Biol Phys 42 155–159

    Google Scholar 

  • C Nieder U Nestle B Motaref K Walter M Niewald K Schnabel (2000) ArticleTitlePrognostic factors in brain metastases: should patients be selected for aggressive treatment according to recursive partitioning analysis (RPA) classes Int J Radiation Oncol Biol Phys 46 297–302

    Google Scholar 

  • GA FitzGerald C Patrono (2001) ArticleTitleThe coxibs, selective inhibitors of cyclooxygenase-2 N Engl J Med 345 433–442 Occurrence Handle10.1056/NEJM200108093450607 Occurrence Handle1:STN:280:DC%2BD3MvltVyltQ%3D%3D Occurrence Handle11496855

    Article  CAS  PubMed  Google Scholar 

  • H Raju E Nakata P Yang RA Newman KK Ang L Milas (2002) ArticleTitleIn vitro enhancement of tumor cell radiosensitivity by a selective inhibitor of cyclooxygenase-2 enzyme: mechanistics considerations Int J Radiation Oncology Biol Phys 54 886–894

    Google Scholar 

  • H Pyo H Choy GP Amorino JS Kim Q Cao SK Hercules RN DuBois (2001) ArticleTitleA selective cyclooxygenase-2 inhibitor, NS-398, enhances the effect of radiation in vitro and in vivo preferentially on the cells that express cyclooxygenase-2 Clin Cancer Res 7 2998–3005

    Google Scholar 

  • L Milas K Kishi N Hunter K Mason JL Masferrer PJ Tofilon (1999) ArticleTitleEnhancement of tumor response to -radiation by an inhibitor of cyclooxygenase-2 enzyme J Natl Cancer Inst 91 1501–1504

    Google Scholar 

  • ChJ Vecht A Hovestadt HB Verbiest JJ Vliet Particlevan WL Putten Particlevan (1994) ArticleTitleDose-effect relationship of dexamethasone on Karnofsky performance in metastatic brain tumors: a randomized study of doses of 4, 8, and 16 mg per day Neurology 44 675–680

    Google Scholar 

  • N Cohen G Strauss R Lew D Silver L Recht (1988) ArticleTitleShould prophylactic anticonvulsants be administered to patients with newly-diagnosed cerebral metastases? A retrospective analysis. JClin Onco 16 1621–1624

    Google Scholar 

  • C Tang M Shou Q Mei TH Rushmore AD Rodrigues (2000) ArticleTitleMajor role of human liver microsomal cytochrome P450 2C9 (CYP2C9) in the oxidative metabolism of celecoxib, a novel cyclooxygenase-ll inhibitor J Pharmacol Exp Ther 293 453–459

    Google Scholar 

  • MM Oken RH Creech DC Tormey J Horton TE Davis ET McFadden PP Carbone (1982) ArticleTitleToxicity and response criteria of the Eastern Cooperative Oncology Group Am J Clin Oncol 5 649–655 Occurrence Handle1:STN:280:BiyC2cbntlU%3D Occurrence Handle7165009

    CAS  PubMed  Google Scholar 

  • MK Jones H Wang BM Peskar E Levin RM Itani IJ Sarfeh AS Tarnawski (1999) ArticleTitleInhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing Nat Med 5 1418–1423 Occurrence Handle10.1038/70995 Occurrence Handle1:CAS:528:DyaK1MXnvFGju7g%3D Occurrence Handle10581086

    Article  CAS  PubMed  Google Scholar 

  • K Kishi S Petersen C Petersen N Hunter K Mason JL Masferrer PJ Tofilon L Milas (2000) ArticleTitlePreferential enhancement of tumor radioresponse by a cyclooxygenase-2 inhibitor Cancer Res 60 1326–1331

    Google Scholar 

  • CS Williams M Mann RN DuBois (1999) ArticleTitleThe role of cyclooxygenases in inflammation, cancer, and development Oncogene 18 7908–7916

    Google Scholar 

  • HS Ryu KH Chang HW Yang MS Kim HC Kwom KS Oh (2000) ArticleTitleHigh cyclooxygenase-2 expression in stage IB cervical cancer with lymph node metastasis or parametrial invasion Gynecol Oncol 76 320–325

    Google Scholar 

  • AS Michalowski (1994) ArticleTitleOn radiation damage to normal tissues and its treatment II. Anti-inflammatory drugs. Acta Oncol 33 139–157

    Google Scholar 

  • L Milas Y Furuta N Hunter I Nishiguchi S Runkel (1990) ArticleTitleDependence of indomethacin-induced potentiation of murine tumor radioresponse on tumor host immunocompetence Cancer Res 50 4473–4477

    Google Scholar 

  • Y Furuta N Hunter T Barkley E Hall L Milas (1988) ArticleTitleIncrease in radioresponse of murine tumors by treatment with indomethacin Cancer Res 48 3008–3013

    Google Scholar 

  • JL Masferrer KM Leahy AT Koki BS Zweifel SL Settle BM Woerner DA Edwards AG Flickinger RJ Moore K Seibert (2000) ArticleTitleAntiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors Cancer Res 60 1306–1311 Occurrence Handle1:CAS:528:DC%2BD3cXhvFWrt74%3D Occurrence Handle10728691

    CAS  PubMed  Google Scholar 

  • AP Dicker TL Williams DS Grant (2001) ArticleTitleTargeting angiogenic processes by combination rofecoxib and ionizing radiation Am J Clin Oncol 24 438–442

    Google Scholar 

  • RA Soslow AJ Dannenberg D Rush BM Woerner KN Khan J Masferrer AT Koki (2000) ArticleTitleCOX-2 is expressed in human pulmonary, colonic, and mammary tumors Cancer 89 2637–2645 Occurrence Handle1:CAS:528:DC%2BD3MXitFWisw%3D%3D Occurrence Handle11135226

    CAS  PubMed  Google Scholar 

  • H Wolff K Saukkonen S Anttila A Karjalainen H Vainio A Ristimaki (1998) ArticleTitleExpression of cyclooxygenase-2 in human lung carcinoma Cancer Res 58 4997–5001

    Google Scholar 

  • D Hwang D Scollard J Byrne E Levine (1998) ArticleTitleExpression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer J Natl Cancer Inst 90 455–460

    Google Scholar 

  • C Denkert M Kobel S Berger A Siegert A Leclere U Trefzer S Hauptmann (2001) ArticleTitleExpression of cyclooxygenase 2 in human malignant melanoma Cancer Res 61 303–308

    Google Scholar 

  • HJ Kim HG Wu IA Park SW Ha (2003) ArticleTitleHigh cyclooxygenase-2 expression is related with distant metastasis in cervical cancer treated with radiotherapy Int J Radiat Oncol Biol Phys 55 16–20

    Google Scholar 

  • L Milas R Komaki T Hachiya RS Bubb JY Ro L Langford R Sawaya JB Putnam P Alien JD Cox TJ McDonnell W Brock WK Hong JA Roth L Milas (2003) ArticleTitleEpidermal growth factor receptor, cyclooxygenase-2, and BAX expression in the primary non-small cell lung cancer and brain metastases Clinical Cancer Res 1 1070–1076

    Google Scholar 

  • MA Hull SW Fenwick KS Chappie N Scott GJ Toogood JP Lodge (2001) ArticleTitleCyclooxygenase-2 expression in colorectal cancer liver metastases Clin Exp Metastasis 18 21–27

    Google Scholar 

  • KK Steinauer I Gibbs S Ning JN French J Armstrong SJ Knox (2000) ArticleTitleRadiation induces upregulation of cyclooxygenase-2 (COX-2) protein in PC-3 cells Int J Rad Oncol Biol Phys 48 325–328

    Google Scholar 

  • L Milas WR Hanson (1995) ArticleTitleEicosanoids and radiation Eur J Cancer 31 A 1580–1585

    Google Scholar 

  • C Petersen S Petersen L Milas FF Lang PJ Tofilon (2000) ArticleTitleEnhancement of intrinsic tumor cell radiosensitivity induced by a selective cyclooxygenase-2 inhibitor Clin Cancer Res 6 2513–2520

    Google Scholar 

  • CS Williams AJ Watson H Sheng R Helou J Shao RN DuBois (2001) ArticleTitleCelecoxib prevents tumor growth in vivo without toxicity to normal gut: lack of correlation between in vitro and in vivo models Cancer Res 60 6045–6051

    Google Scholar 

  • P Wachsberger R Burd AP Dicker (2003) ArticleTitleTumor response to ionizing radiation combined with antiangiogenesis or vascular targeting agents: exploring mechanisms of interaction Clin Cancer Res 9 1957–1971

    Google Scholar 

  • R Burd H Choy A Dicker (2003) Potential for inhibitors of cyclooxygenase-2 to enhance tumor radioresponse RE Harris (Eds) COX-2 Blockade in Cancer Prevention and Therapy Humana Press Inc Totowa, New Jersey 301–311

    Google Scholar 

  • RD Blumenthal C Waskewich DM Goldenberg W Lew C Flefleh J Burton (2001) ArticleTitleChronotherapy and chronotoxicity of the cyclooxygenase-2 inhibitor, celecoxib, in athymic mice bearing human breast cancer xenografts Clin Cancer Res 7 3178–3185

    Google Scholar 

  • E Stormer S Bauer J Kirchheiner J Brockmoller I Roots (2003) ArticleTitleSimultaneous determination of celecoxib, hydrocelecoxib, and carboxycelecoxib in human plasma using gradient reversed-phase liquid chromatography with ultraviolet absorbance detection J Chromatogr B Analyt Technol Biomed Life Sci 783 207–212

    Google Scholar 

  • P Davey (2002) ArticleTitleBrain Metastases: treatment options to improve outcomes CNS Drugs 16 325–338 Occurrence Handle1:CAS:528:DC%2BD38Xks1Omtrw%3D Occurrence Handle11994022

    CAS  PubMed  Google Scholar 

  • KJ Murray C Scott HM Greenberg B Emami M Seider NL Vora C Olson A Whitton B Movsas W Curran (1997) ArticleTitleA randomized phase III study of accelerated hyperfractionation versus standard in patients with unresected brain metastases: a report of the radiation therapy oncology group (RTOG) 9104 Int J Radial Oncol Biol Phys 39 571–574

    Google Scholar 

  • BB Ma RG Bristow J Kim LL Siu (2003) ArticleTitleCombined-modality treatment of solid tumors using radiotherapy and molecular targeted agents J Clin Oncol 21 2760–2776

    Google Scholar 

  • JA Bonner KP Raisch HQ Trummell F Robert RF Meredith SA Spencer DJ Buchsbaum MN Saleh MA Stackhouse AF LoBuglio GE Peters WR Carroll HW Waksal (2000) ArticleTitleEnhanced apoptosis with combination C225/radiation treatment serves as the impetus for clinical investigation in head and neck J Clin Oncol 18 IssueID1 47–53

    Google Scholar 

  • C Bianco R Bianco G Tortora V Damiano P Guerrieri P montemaggi J Mendelsohn S Placido ParticleDe AR Bianco F Ciardiello (2000) ArticleTitleAntitumor activity of combined treatment of human cancer cells with ionizing radiation and anti-epidermal growth factor receptor monoclonal antibody C225 plus type I protein kinase A antisense oligonucleotide Clin Cancer Res 6 4343–4350

    Google Scholar 

  • L Milas K Mason N Hunter S Petersen M Yamakawa K Ang J Mendelsohn Z Fan (2000) ArticleTitleIn vivo enhancement of tumor radioresponse by C225 antiepidermal growth factor receptor antibody Clin Cancer Res 6 701–708

    Google Scholar 

  • JA Bonner J Maihle BR Folven TJ Christianson K Spain (1994) ArticleTitleThe interaction of epidermal growth factor and radiation in human head and neck squamous cell carcinoma cell lines with vastly different radiosensitivities Int J Radiat Oncol Biol Phys 29 243–247

    Google Scholar 

  • HD Thames HR Withers LJ Peters GH Fletcher (1982) ArticleTitleChanges in early and late radiation responses with altered dose fractionation: implications for dose-survival relationships Int J Radiat Oncol Biol Phys 8 219–222

    Google Scholar 

  • MR Mehrabi N Serbecic F Tamaddon C Kaun K Huber R Pacher T Wild G Mall J Wojta HD Glogar (2002) ArticleTitleClinical and experimental evidence of prostaglandin E1-induced angiogenesis in the myocardium of patients with ischemic heart disease Cardiovasc Res 56 214–224

    Google Scholar 

  • BM Fenton BK Beauchamp SF Paoni P Okunieff I Ding (2001) ArticleTitleCharacterization of the effects of antiangiogenic agents on tumor pathophysiology Am J Clin Oncol 24 453–457

    Google Scholar 

  • C Nieder N Andratschke AL Grosu M Molls (2003) ArticleTitleRecursive partitioning analysis (RFA) class does not predict survival in patients with four or more brain metastases Strahlenther Onkol 1 16–20

    Google Scholar 

  • D Kondziolka A Patel LD Lunsford A Kassam JC Flickinger (1999) ArticleTitleStereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases Int J Rad Oncol Biol Phys 45 427–434

    Google Scholar 

  • PH Gutin (1977) ArticleTitleCorticosteroid therapy in patients with brain tumors Natl Cancer inst Monogr 28 8–14

    Google Scholar 

  • DE Weissman D Dufer V Vogel MD Abeloff (1987) ArticleTitleCorticosteroid toxicity in neuro-oncology patients J Neuroncol 5 125–128

    Google Scholar 

  • LF Marshall JK King TW Langfitt (1977) ArticleTitleThe complications of high-dose Corticosteroid therapy in neurosurgical patients: a prospective study Ann Neurol 1 201–203

    Google Scholar 

  • S Kyrkanides AH Moore JA Olschowka JC Daeschner JP Williams JT Hansen M Kerry O’Banion (2002) ArticleTitleCyclooxygenase-2 modulates barin inflammation-related gene expression in central nervous System radiation injury Mol Brain Res 104 159–169

    Google Scholar 

  • J Portnow S Suleman SA Grossman S Eller K Carson (2002) ArticleTitleA cyclooxygenase-2 (COX-2) inhibitor compared with dexamethasone in a survival study of rats with intracerebral 9L gliosarcomas Neuro-oncol 4 22–25

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Translational Research Unit, Universidad de Buenos Aires, Argentina

    Leandro C. A. Cerchietti, Alfredo H. Navigante & Monica A. Castro

  2. Department of Radiotherapy and Radiology, Universidad de Buenos Aires, Argentina

    Marcelo R. Bonomi & Berta M. C. Roth

  3. Department of Internal Medicine, Instituto de Oncologia Angel H. Roffo, Universidad de Buenos Aires, Ciudad de Buenos Aires, Argentina

    Alfredo H. Navigante & Maria E. Cabalar

  4. Albert Einstein Cancer Center, Chanin Building, Room 517, 1300 Morris Park Avenue, Bronx, New York, 10461, USA

    Leandro C. A. Cerchietti

Authors
  1. Leandro C. A. Cerchietti
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Marcelo R. Bonomi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Alfredo H. Navigante
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Monica A. Castro
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Maria E. Cabalar
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Berta M. C. Roth
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Leandro C. A. Cerchietti.

Additional information

This Article Presented in part at the Second International Conference on Translational Research and Preclinical Strategies in Radiation Oncology, March 2003, Lugano, Switzerland.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cerchietti, L.C.A., Bonomi, M.R., Navigante, A.H. et al. Phase I/II study of selective cyclooxygenase-2 inhibitor celecoxib as a radiation sensitizer in patients with unresectable brain metastases. J Neurooncol 71, 73–81 (2005). https://doi.org/10.1007/s11060-004-9179-x

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11060-004-9179-x

Keywords

Search

Navigation